114 related articles for article (PubMed ID: 30662617)
1. Cyclin-dependent kinase 7 inhibitor THZ2 inhibits the growth of human gastric cancer
Huang JR; Qin WM; Wang K; Fu DR; Zhang WJ; Jiang QW; Yang Y; Yuan ML; Xing ZH; Wei MN; Li Y; Shi Z
Am J Transl Res; 2018; 10(11):3664-3676. PubMed ID: 30662617
[TBL] [Abstract][Full Text] [Related]
2. Targeting Super-Enhancer-Associated Oncogenes in Osteosarcoma with THZ2, a Covalent CDK7 Inhibitor.
Zhang J; Liu W; Zou C; Zhao Z; Lai Y; Shi Z; Xie X; Huang G; Wang Y; Zhang X; Fan Z; Su Q; Yin J; Shen J
Clin Cancer Res; 2020 Jun; 26(11):2681-2692. PubMed ID: 31937612
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of CDK7 in gastric cancer cell promotes tumor cell proliferation and predicts poor prognosis.
Wang Q; Li M; Zhang X; Huang H; Huang J; Ke J; Ding H; Xiao J; Shan X; Liu Q; Bao B; Yang L
Exp Mol Pathol; 2016 Jun; 100(3):514-21. PubMed ID: 27155449
[TBL] [Abstract][Full Text] [Related]
4. Discovery of a Dual-Target Inhibitor of CDK7 and HDAC1 That Induces Apoptosis and Inhibits Migration in Colorectal Cancer.
Chen Y; Zhang S; Li Z; Yin B; Liu Y; Zhang L
ChemMedChem; 2023 Dec; 18(23):e202300281. PubMed ID: 37821774
[TBL] [Abstract][Full Text] [Related]
5. CDK7 inhibitor suppresses tumor progression through blocking the cell cycle at the G2/M phase and inhibiting transcriptional activity in cervical cancer.
Zhong S; Zhang Y; Yin X; Di W
Onco Targets Ther; 2019; 12():2137-2147. PubMed ID: 30962695
[TBL] [Abstract][Full Text] [Related]
6. AZ703, an imidazo[1,2-a]pyridine inhibitor of cyclin-dependent kinases 1 and 2, induces E2F-1-dependent apoptosis enhanced by depletion of cyclin-dependent kinase 9.
Cai D; Byth KF; Shapiro GI
Cancer Res; 2006 Jan; 66(1):435-44. PubMed ID: 16397259
[TBL] [Abstract][Full Text] [Related]
7. Volasertib suppresses the growth of human hepatocellular carcinoma
Zheng DW; Xue YQ; Li Y; Di JM; Qiu JG; Zhang WJ; Jiang QW; Yang Y; Chen Y; Wei MN; Huang JR; Wang K; Wei X; Shi Z
Am J Cancer Res; 2016; 6(11):2476-2488. PubMed ID: 27904765
[TBL] [Abstract][Full Text] [Related]
8. Impact of roscovitine, a selective CDK inhibitor, on cancer cells: bi-functionality increases its therapeutic potential.
Wesierska-Gadek J; Borza A; Komina O; Maurer M
Acta Biochim Pol; 2009; 56(3):495-501. PubMed ID: 19724778
[TBL] [Abstract][Full Text] [Related]
9. Ginsenoside Rg5 induces G2/M phase arrest, apoptosis and autophagy via regulating ROS-mediated MAPK pathways against human gastric cancer.
Liu Y; Fan D
Biochem Pharmacol; 2019 Oct; 168():285-304. PubMed ID: 31301277
[TBL] [Abstract][Full Text] [Related]
10. Sildenafil inhibits the growth of human colorectal cancer in vitro and in vivo.
Mei XL; Yang Y; Zhang YJ; Li Y; Zhao JM; Qiu JG; Zhang WJ; Jiang QW; Xue YQ; Zheng DW; Chen Y; Qin WM; Wei MN; Shi Z
Am J Cancer Res; 2015; 5(11):3311-24. PubMed ID: 26807313
[TBL] [Abstract][Full Text] [Related]
11. The Cyclin-dependent kinase inhibitor CYC202 (R-roscovitine) inhibits retinoblastoma protein phosphorylation, causes loss of Cyclin D1, and activates the mitogen-activated protein kinase pathway.
Whittaker SR; Walton MI; Garrett MD; Workman P
Cancer Res; 2004 Jan; 64(1):262-72. PubMed ID: 14729633
[TBL] [Abstract][Full Text] [Related]
12. Diallyl trisulfide induces apoptosis and mitotic arrest in AGS human gastric carcinoma cells through reactive oxygen species-mediated activation of AMP-activated protein kinase.
Choi YH
Biomed Pharmacother; 2017 Oct; 94():63-71. PubMed ID: 28753455
[TBL] [Abstract][Full Text] [Related]
13. Cyclin-dependent kinase 7 is a therapeutic target in high-grade glioma.
Greenall SA; Lim YC; Mitchell CB; Ensbey KS; Stringer BW; Wilding AL; O'Neill GM; McDonald KL; Gough DJ; Day BW; Johns TG
Oncogenesis; 2017 May; 6(5):e336. PubMed ID: 28504693
[TBL] [Abstract][Full Text] [Related]
14. SC-III3, a novel scopoletin derivative, induces cytotoxicity in hepatocellular cancer cells through oxidative DNA damage and ataxia telangiectasia-mutated nuclear protein kinase activation.
Zhao P; Chen L; Li LH; Wei ZF; Tong B; Jia YG; Kong LY; Xia YF; Dai Y
BMC Cancer; 2014 Dec; 14():987. PubMed ID: 25527123
[TBL] [Abstract][Full Text] [Related]
15. Discovery of Pongol, the Furanoflavonoid, as an Inhibitor of CDK7/Cyclin H/MAT1 and Its Preliminary Structure-Activity Relationship.
Bhurta D; Bharate SB
ACS Omega; 2023 Jan; 8(1):1291-1300. PubMed ID: 36643464
[TBL] [Abstract][Full Text] [Related]
16. SKLB316, a novel small-molecule inhibitor of cell-cycle progression, induces G2/M phase arrest and apoptosis in vitro and inhibits tumor growth in vivo.
Xia Y; Lei Q; Zhu Y; Ye T; Wang N; Li G; Shi X; Liu Y; Shao B; Yin T; Zhao L; Wu W; Song X; Xiong Y; Wei Y; Yu L
Cancer Lett; 2014 Dec; 355(2):297-309. PubMed ID: 25301449
[TBL] [Abstract][Full Text] [Related]
17. Decitabine, a DNA methyltransferases inhibitor, induces cell cycle arrest at G2/M phase through p53-independent pathway in human cancer cells.
Shin DY; Sung Kang H; Kim GY; Kim WJ; Yoo YH; Choi YH
Biomed Pharmacother; 2013 May; 67(4):305-11. PubMed ID: 23582784
[TBL] [Abstract][Full Text] [Related]
18. Apigetrin inhibits gastric cancer progression through inducing apoptosis and regulating ROS-modulated STAT3/JAK2 pathway.
Sun Q; Lu NN; Feng L
Biochem Biophys Res Commun; 2018 Mar; 498(1):164-170. PubMed ID: 29408335
[TBL] [Abstract][Full Text] [Related]
19. Piperlongumine induces gastric cancer cell apoptosis and G2/M cell cycle arrest both in vitro and in vivo.
Duan C; Zhang B; Deng C; Cao Y; Zhou F; Wu L; Chen M; Shen S; Xu G; Zhang S; Duan G; Yan H; Zou X
Tumour Biol; 2016 Aug; 37(8):10793-804. PubMed ID: 26874726
[TBL] [Abstract][Full Text] [Related]
20. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
